GAMA reveals plans for £2m R&D facility

GAMA Healthcare, a leader in the manufacture and development of infection prevention products for the healthcare sector, has outlined plans to build a new research and development facility in the Greetland area of Halifax.

The proposed development, spread across 11,765 sq ft, is projected to cost £2 million and comprises a contemporary open-office environment with advanced research laboratories and auxiliary space to produce and test product samples.

Managing director and co-founder of GAMA Healthcare, Dr Guy Braverman said: “Plans for the new R&D facility are geared towards facilitating an up-to-date environment for research and innovation breakthroughs with industry leading practices. The laboratories will be capable of conducting detailed up-to-date research in all aspects of microbiology, infection control and analytical chemistry. A pilot plant is being incorporated to allow experimental small product runs enabling our teams to conduct trials and be proactive with quality assurance and internal testing. The facility will also incorporate a mock hospital room to replicate real life scenarios.”

 

Other news

Upcoming Events

Health+Care 2017

ExCeL London
28th - 29th June 2017

The British Society of Audiology Annual Conference

Majestic Hotel, Harrogate
29th – 30th June 2017

Infection Prevention & Control 2017

Centenary Pavilion, Elland Road Stadium, Leeds
Wednesday 12th July 2017

AfPP annual residential conference 2017

University of York
10th - 12th August

NPAG - Clinical Engineering and IT Connectivity Conference 2017

Ricoh Arena - Coventry
12th September 2017

Latest Issue

Clinical Services Journal

Clinical Services Journal

Jun 2017

Providing an insight into patient experience

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.